Inventor · disambiguated record
Harald Wajant
Also filed as: WAJANT HARALD
7 granted patents·6 pending applications·90 citations·filing 2003–2023
85Inventor score
Top patents by PatentIndex Score
13 records- 0194US9765149B2Antibodies to CD70ARGEN-X N V·Filed 2014·Granted Sep 19, 2017·24 cites·22 claims
- 0294US9765148B2Antibodies to CD70SILENCE KAREN·Filed 2012·Granted Sep 19, 2017·32 cites·13 claims
- 0394US8834882B2Antibodies to CD70SILENCE KAREN·Filed 2013·Granted Sep 16, 2014·30 cites·12 claims
- 0483US11434298B2Antibodies to CD70argenx BV·Filed 2019·Granted Sep 6, 2022·1 cites·11 claims
- 0583US11072665B2Antibodies to CD70ARGENX BVBA·Filed 2015·Granted Jul 27, 2021·2 cites·39 claims
- 0681US2023265201A1Antibodies to cd70argenx BV·Filed 2022·Application pending·0 cites
- 0758US8980265B2Site-specific antibody-mediated activation of proapoptotic cytokines: AMAIZEe (antibody-mediated apoptosis inducing cytokines)PFIZENMAIER KLAUS·Filed 2003·Granted Mar 17, 2015·1 cites·3 claims
- 0856US9944708B2Site-specific antibody-mediated activation of proapoptotic cytokines: AMAIZe (antibody-mediated apoptosis inducing cytokines)BIONTECH AG·Filed 2014·Granted Apr 17, 2018·0 cites·5 claims
- 0956US2025277046A1Antibody-based soluble and membrane-bound tweak mimicking agonists with fcyr-independent activityUNIV WUERZBURG J MAXIMILIANS·Filed 2023·Application pending·0 cites
- 1053US2024190983A1Novel TNFR2 Binding MoleculesUNIV WUERZBURG J MAXIMILIANS·Filed 2022·Application pending·0 cites
- 1150US2004126791A1Compositions and methods for treating trail-resistant cancer cellsRIBOPHARMA AG·Filed 2003·Application pending·0 cites
- 1240US2021079106A1TUMOR NECROSIS FACTOR (TNF) RECEPTOR SUPERFAMILY (TNFRSF) RECEPTOR-ACTIVATING ANTIBODY FUSION PROTEINS WITH FCgR-INDEPENDENT AGONISTIC ACTIVITY (TNFRSF RECEPTOR-ACTIVATING ANTIBODY FUSION PROTEINS WITH FCgR-INDEPENDENT AGONISTIC ACTIVITY; TRAAFFIAA)UNIV WUERZBURG J MAXIMILIANS·Filed 2018·Application pending·0 cites
- 1339US2005244370A1Selective local activation of members of the TNF receptor family by systemically inactive non-antibody TNF ligand fusion proteinsPFIZENMAIER KLAUS·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Harald Wajant files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →